Pumitamig
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for Pumitamig, covering 2026-03-12 to 2026-04-24. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Preliminary Efficacy of Pumitamig (BNT327), an Investigational Therapy for Patients With Non-small Cell Lung Cancer in Combination With Chemotherapy as First-line or Second-line Treatment [Phase 2]